Selected article for: "antibody epitope and China SARS"

Author: Wang, Chunyan; Li, Wentao; Drabek, Dubravka; Okba, Nisreen M. A.; van Haperen, Rien; Osterhaus, Albert D. M. E.; van Kuppeveld, Frank J. M.; Haagmans, Bart L.; Grosveld, Frank; Bosch, Berend-Jan
Title: A human monoclonal antibody blocking SARS-CoV-2 infection
  • Cord-id: 9n7bkayx
  • Document date: 2020_5_4
  • ID: 9n7bkayx
    Snippet: The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.
    Document: The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • lonza streptomycin and luciferase activity: 1
    • lonza streptomycin and luciferase reporter: 1
    • luciferase reporter and lymph node: 1, 2, 3, 4
    • luciferase reporter gene and lymph node: 1